Compound Detail
CHEMBL216772
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)CCC(=O)O)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)O
Basic Information
| ChEMBL ID | CHEMBL216772 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HOFHLVNYTOGMEY-BCELNCAISA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
1447.6
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.1016/0960-894X(96)00421-0 | Endothelin receptor type B | 1 |
| - | 10.1016/0960-894X(96)00421-0 | Endothelin-1 receptor | 1 |
Data from ChEMBL 36 via Core Engine